Member Info for goupplease

For patience in 2018

Taking long time

Well under ipo ,small free float . It's all about 2018

More buys ,nothing great but steady ,nice and easy

The vox interview with Dan Gooding was a masterclass.

For investors here ,sound future , day to day share price irrelevant with 2018 news, one for the future imho

Ipo was 4p , 2018 looking very good here. I like nuformix Dan Gooding great knowledge of his products unlike your run of the mill ceo

Great but for me it's not about tomorrow or even this year bring on 2018. Research sells it to me.

https://www.**********.co.uk/blogs/nuformix-nfx/ All good news

Chalmer15 . Posts negative on msmn board as well surely decent members should not have to put up with this thanks. By his tone he has no investment in either

nfx on vox tomorrow ,should see good rise

this is the time to get in below 4p Ipo

This reminds me of uru trolls ,who would spend weekend spouting rubbish for no reason.

Hiblue temporary mate chasing the rainbow last week different one this week. Let's hope admin get to grips with the multi id probs , Vox tomorrow ,back to blue Patience as ever

https://nuformix.com/about-nuformix/team/

This is on the main market not aim.

Address Ste 31 Second Fl, 107 Cheapside LONDON, EC2V 6DN United Kingdom - Map Website links http://www.levrett.com External links Analyst Estimates - BusinessWeek Options - MarketWatch Research Reports - Reuters Director Dealings - Yahoo Finance Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of multiple fibrotic diseases. NXP003 targets a mechanism understood to confer resistance to immuno-oncology, chemotherapy and radiotherapy cancer treatments.

Hope you sort out the multi ID users on Nfx

Member since 24th Nov Muti ID for me ?

Aim is all about timing and not being greedy ,